SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001571049-18-000206
Filing Date
2018-03-30
Accepted
2018-03-30 16:31:51
Documents
84
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv489461-10k.htm 10-K 1284655
2 EXHIBIT 23.1 tv489461_ex23-1.htm EX-23.1 1932
3 EXHIBIT 31.1 tv489461_ex31-1.htm EX-31.1 9442
4 EXHIBIT 31.2 tv489461_ex31-2.htm EX-31.2 9491
5 EXHIBIT 32.1 tv489461_ex32-1.htm EX-32.1 3921
6 EXHIBIT 32.2 tv489461_ex32-2.htm EX-32.2 3972
  Complete submission text file 0001571049-18-000206.txt   5737647

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cycc-20171231.xml EX-101.INS 1063371
8 XBRL SCHEMA FILE cycc-20171231.xsd EX-101.SCH 53556
9 XBRL CALCULATION FILE cycc-20171231_cal.xml EX-101.CAL 46157
10 XBRL DEFINITION FILE cycc-20171231_def.xml EX-101.DEF 197869
11 XBRL LABEL FILE cycc-20171231_lab.xml EX-101.LAB 492100
12 XBRL PRESENTATION FILE cycc-20171231_pre.xml EX-101.PRE 344955
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 18726413
SIC: 2834 Pharmaceutical Preparations